Watch TRLV. Know when insiders buy.
One email the day a filing lands. Free.
TRLV
Trulieve Cannabis Corp.
10.87
−0.03 −0.28%
USD · close Oct 1
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
31
FLAG · shorts 31
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.1BP/E —DIV YIELD —FCF YIELD 9.29%REV TTM $1.1B −3.9%NET INCOME −$476.2MNET CASH $129.6M52W 4.76 – 13.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $271M | −10.3% | 59.9% | −$370.5M | −$406.1M | — | — | $53.1M | $21M | $32.1M | Aug 7 |
| Q1 2026 · Mar 31 | $286.8M | −3.7% | 59.3% | $35.7M | $2.3M | — | — | $55.7M | $13.5M | $42.2M | May 7 |
| Q4 2025 · Dec 31derived | $293.1M | −2.7% | 59.8% | $15.3M | −$43.6M | — | — | $59.2M | $3.4M | $55.8M | Feb 26 |
| Q3 2025 · Sep 30 | $288.2M | +1.4% | 58.9% | $42.2M | −$28.8M | — | — | $76.4M | $12.3M | $64.1M | Nov 5 |
| Q2 2025 · Jun 30 | $302.1M | −0.4% | 60.6% | $52.6M | −$16.1M | — | — | $86.1M | $11.6M | $74.5M | Aug 7 |
| Q1 2025 · Mar 31 | $297.8M | +0.0% | 61.5% | $33.3M | −$33.8M | — | -0.16 | $51.1M | $16.9M | $34.2M | May 7 |
| Q4 2024 · Dec 31derived | $301.1M | +4.9% | 62.1% | $1.3M | −$62.5M | — | -0.27 | $30.7M | $42.7M | −$12M | Feb 26 |
| Q3 2024 · Sep 30 | $284.3M | +3.3% | 61.0% | $618K | −$61.6M | — | -0.32 | $30.3M | $38.1M | −$7.8M | Nov 5 |
| Q2 2024 · Jun 30 | $303.4M | — | 59.9% | $49.8M | −$12M | — | -0.04 | $71.3M | $26.3M | $45M | Aug 6 |
| Q1 2024 · Mar 31 | $297.6M | — | 58.4% | $46.1M | −$24.5M | — | -0.16 | $139.2M | $15.5M | $123.7M | May 7 |
| Q4 2023 · Dec 31derived | $287M | — | 53.6% | $29.2M | −$34.8M | — | -0.19 | $131.5M | $9.2M | $122.2M | Feb 26 |
| Q3 2023 · Sep 30 | $275.2M | — | 51.9% | $23.3M | −$25.8M | — | -0.12 | $93.4M | $6.3M | $87.2M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.2B | 60.2% | $143.5M | −$122.2M | -10.3% | -0.58 | $272.8M | $44.2M | $228.6M | — | — |
| FY2024 · to Dec 31 | $1.2B | 60.3% | $97.8M | −$160.6M | -13.5% | -0.79 | $271.5M | $122.6M | $148.9M | — | — |
| FY2023 · to Dec 31 | $1.1B | 52.1% | −$221.6M | −$533.1M | -47.2% | -2.28 | $201.8M | $40.2M | $161.6M | — | — |
| FY2022 · to Dec 31 | $1.2B | 56.6% | $50.2M | −$252.7M | -20.7% | -0.95 | $23.1M | $164.7M | −$141.7M | — | — |
| FY2021 · to Dec 31 | $931.9M | 60.8% | $204.1M | $17.4M | 1.9% | 0.21 | $12.9M | $275.9M | −$263M | — | — |
| FY2020 · to Dec 31 | $521.5M | 74.1% | $218.3M | $63M | 12.1% | 0.53 | $99.6M | $99.9M | −$298K | — | — |
Every number comes from Trulieve Cannabis Corp.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.